Back to search

Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.

Data up to Jan 2025

Published1981
Citations68
References32

Total Citations Per Year

Abstract

References (32)

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1978 • 612 citations

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1978 • 364 citations

An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive Patients

1974 • 349 citations

ALDOSTERONE SECRETION AND PRIMARY AND MALIGNANT HYPERTENSION *

1960 • 308 citations

IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRIL

1980 • 305 citations

Antihypertensive action of propranolol

1973 • 256 citations

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

1977 • 246 citations

Converting enzyme inhibition with an orally active compound in hypertensive man.

1979 • 224 citations

LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION

1979 • 191 citations

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.

1979 • 185 citations

Renin Release during Acute Reduction of Arterial Pressure in Normotensive Subjects and Patients with Renovascular Hypertension*

1967 • 181 citations

Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.

1976 • 165 citations

Plasma Renin Concentration in Human Hypertension. 1: Relationship Between Renin, Sodium, and Potassium

1965 • 146 citations

Proteinuria During Long-term Captopril Therapy

1980 • 101 citations

Blindness after treatment for malignant hypertension.

1979 • 99 citations

Hydralazine and Plasma Renin Activity

1968 • 79 citations

Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.

1979 • 78 citations

Reactive Hyperreninemia in Renovascular Hypertension After Angiotensin Blockade with Saralasin or Converting Enzyme Inhibitor

1979 • 76 citations

Clinical use of an orally acting converting enzyme inhibitor: captopril.

1980 • 74 citations

Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.

1979 • 73 citations

Hypertensive Emergencies

1974 • 71 citations

TREATMENT OF HYPERTENSION WITH PROPRANOLOL AND HYDRALAZINE

1971 • 68 citations

Disparate Patterns of Aldosterone Response During Diuretic Treatment of Hypertension

1977 • 59 citations

Use of First-Dose Response or Plasma Renin Activity to Predict the Long-Term Effect of Captopril

1980 • 54 citations

Low-Renin Hypertension

1974 • 43 citations

A Role for Renin in Rebound Hypertension and Encephalopathy after Infusion of Saralasin Acetate (Sar1-Ala8-Angiotensin II)

1976 • 41 citations

Management of severe hypertension

1973 • 38 citations

Converting Enzyme Inhibition in Hypertensive Emergencies

1979 • 35 citations

Acute and chronic effect of captropril in hypertensive patients.

1980 • 28 citations

Minoxidil Therapy in Refractory Hypertension Analysis of 155 Patients

1978 • 27 citations

Reactive Hyper-Reninaemia to Angiotensin Blockade Identifies Renovascular Hypertension

1979 • 27 citations

Current Treatment of Malignant Hypertension

1975 • 10 citations

Cited By (0)

Loading...
Acute and chronic treatment of severe and malignant hypertension with the oral… (1981) – Circulation | Metascience Observatory Explorer